Global Biopharmaceutical Selects CIS for Commercial Optimization

CIS announced that a global biopharmaceutical company offering products for the treatment and management of liver diseases has chosen CIS to manage its compliance requirements for ongoing Government Programs (GP) pricing calculations, state price reporting, and Public Health Service contract management.

CIS Event

CIS Wraps Up Year with Compliance Focused Webinars

CIS has announced the line up of three complimentary webinars over the next two months to address hot topics in commercial and government programs compliance.

CIS Event